Latest evidence update: 2025-01-26
Strongest in Recency (100). Held back by Sample size (42).
Solid mix of RCTs with some methodological gaps.
Some independent replication, statistical precision uneven.
Hundreds of participants; meaningful but not large.
Mostly aligned, with some divergence.
Most studies are recent (last 2-3 years).
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
A multi-herb adaptogen formula (VL-G-A57) containing rhodiola, holy basil, and Schisandra chinensis significantly reduced Perceived Stress Scale scores at day 60 compared to placebo.
VL-G-A57 (rhodiola, holy basil, Schisandra chinensis) significantly improved restorative sleep as measured by Restorative Sleep Questionnaire-Weekly at day 60 compared to placebo.
VL-G-A57 (rhodiola, holy basil, Schisandra chinensis) significantly reduced mood dysregulation at day 60 compared to placebo.
VL-G-A57 (rhodiola, holy basil, Schisandra chinensis) significantly improved sleep quality as measured by Pittsburgh Sleep Quality Index at day 60 compared to placebo.
Intravenous tenecteplase administered within 24 hours after basilar artery occlusion stroke onset improved functional outcome (mRS 0-1 or return to baseline) compared with standard medical treatment at 90 days.
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.